Literature DB >> 32522070

The application of medical scale in the treatment of plantar warts: analysis and prospect.

Kai Huang1,2, Mingjia Li3, Yi Xiao1,2, Lisha Wu1,2, Yixin Li3, Yang Yang3, Guanzhong Shi3, Nianzhou Yu1,2, Dihui Liu1,2, Juan Su1,2, Xianggui Wang4, Shuang Zhao1,2, Xiang Chen1,2.   

Abstract

Plantar warts are common cutaneous diseases on the sole caused by the human papillomavirus, with a high annual incidence rate of 14%. It often causes pain, which impairs quality of life of patients. Numerous therapeutic options for plantar warts exist with variable success. However, all of them, including first-line treatment, have different adverse reactions or high recurrence rates. There is no one effective method for all patients. The choice of treatment method puzzles doctors. With the help of medical scales, we can analyze the patients' condition, so as to guide the choice of treatment methods, which is of great significance for the individualized treatment of patients with plantar warts. This review takes cryotherapy, intralesional injection of bleomycin and photodynamic therapy as examples to discuss the application of medical scales in the treatment of plantar warts, summarizes the scales that can be used to evaluate the status of plantar wart, adverse reactions, prognosis and patient's financial situation, and discusses their clinical and scientific value. We hope to use scales to consider the severity of plantar warts and economic level, help different patients to choose different treatment options, and make suggestions on the evaluation of the adverse reactions and treatment effect.

Entities:  

Keywords:  Plantar wart; medical scale; treatment

Mesh:

Substances:

Year:  2020        PMID: 32522070     DOI: 10.1080/09546634.2020.1781757

Source DB:  PubMed          Journal:  J Dermatolog Treat        ISSN: 0954-6634            Impact factor:   3.359


  1 in total

1.  Exosomal miR-486-5p derived from human placental microvascular endothelial cells regulates proliferation and invasion of trophoblasts via targeting IGF1.

Authors:  Ruixia Ma; Zhijiang Liang; Xiaomei Shi; Linli Xu; Xiaowei Li; Jinhua Wu; Lina Zhao; Guocheng Liu
Journal:  Hum Cell       Date:  2021-05-11       Impact factor: 4.174

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.